AIP
AYTU icon

Ameritas Investment Partners’s AYTU BioPharma AYTU Stock Holding History

Ameritas Investment Partners’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-89
Closed -$14K – 3062
2021
Q1 		$14K Buy
89
+79
+790% +$12.5K ﹤0.01% 2705
2020
Q4 		$1K Hold
10
– – ﹤0.01% 3059
2020
Q3 		$2K Hold
10
– – ﹤0.01% 3062
2020
Q2 		$3K Buy
+10
New +$3.03K ﹤0.01% 3014

Other funds holding AYTU

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Ameritas Investment Partners's AYTU Position: Q2 2021 in Review

Ameritas Investment Partners sold out of AYTU BioPharma (AYTU) in Q2 2021, closing a stake of 89 shares — an estimated $14K sold.

Ameritas Investment Partners first reported a position in AYTU in Q2 2020 and held it in 4 quarters. The position peaked at $14K in Q1 2021. 50 funds tracked by Wall St. Rank hold AYTU as of Q2 2021.

  • Ameritas Investment Partners reported no remaining AYTU BioPharma position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Partners sold 89 AYTU BioPharma shares in Q2 2021, an estimated $14K.
  • Ameritas Investment Partners first reported a position in AYTU BioPharma in Q2 2020 and held it in 4 quarters.
  • Ameritas Investment Partners's AYTU BioPharma position peaked at $14K in Q1 2021.
  • 50 funds tracked by Wall St. Rank held AYTU BioPharma as of Q2 2021.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.